Profil
Kamalam Unninayar served as the Chief Financial Officer at Harvard Bioscience, Inc. from 2018 to 2019 and at Tetraphase Pharmaceuticals, Inc. from 2017 to 2018.
She received a graduate degree from Wichita State University and both undergraduate and graduate degrees from the University of Delhi.
Ehemalige bekannte Positionen von Kamalam Unninayar
Unternehmen | Position | Ende |
---|---|---|
HARVARD BIOSCIENCE, INC. | Finanzdirektor/CFO | 31.05.2019 |
TETRAPHASE PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 16.03.2018 |
Ausbildung von Kamalam Unninayar
Wichita State University | Graduate Degree |
University of Delhi | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
HARVARD BIOSCIENCE, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |